Literature DB >> 28112712

[Pathophysiology of diabetic nephropathy: a literature review].

Carlos Eduardo Meza Letelier1, Camilo Alfredo San Martín Ojeda2, José Javier Ruiz Provoste2, Cristobal Jesus Frugone Zaror2.   

Abstract

Chronic kidney disease is a common complication of diabetes. Its importance lies in its high prevalence and future projection. It is associated with high health costs and global cardiovascular deterioration as well. The development of this disease pathophysiology is being studied and it is known that a series of complex molecular pathways determining a microvascular disease are involved. This review addresses the known pathways in the development of diabetic nephropathy aiming to improve the understanding of potential therapeutic targets that could be developed in the future.

Entities:  

Keywords:  chronic renal disease physiopathology; microvascular complications; diabetic nephropathy

Mesh:

Year:  2017        PMID: 28112712     DOI: 10.5867/medwave.2017.01.6839

Source DB:  PubMed          Journal:  Medwave        ISSN: 0717-6384


  16 in total

1.  Effects of Qidantang Granule on early stage of diabetic kidney disease in rats.

Authors:  Tengfei Wu; Xinyu Yang; Yilei Cong; Shisi Xia; Bowen Liu; Ran Zou; Juanhua Zeng; Hua Yang
Journal:  Aging (Albany NY)       Date:  2022-06-13       Impact factor: 5.955

2.  Exosomal circTAOK1 contributes to diabetic kidney disease progression through regulating SMAD3 expression by sponging miR-520h.

Authors:  Bo Li; Guijiang Sun; Haibo Yu; Jia Meng; Fang Wei
Journal:  Int Urol Nephrol       Date:  2022-02-10       Impact factor: 2.266

Review 3.  Human umbilical cord mesenchymal stem cells in type 2 diabetes mellitus: the emerging therapeutic approach.

Authors:  Andreia Gomes; Pedro Coelho; Raquel Soares; Raquel Costa
Journal:  Cell Tissue Res       Date:  2021-05-29       Impact factor: 5.249

Review 4.  New insights into diabetes mellitus and its complications: a narrative review.

Authors:  Fei Hua
Journal:  Ann Transl Med       Date:  2020-12

5.  The Efficacy of Hydroxychloroquine Combined with Huangqi Tablets in the Treatment of Diabetic Nephropathy.

Authors:  Xiaorong Chen; Danhong Sheng; Xiangdong Kong
Journal:  J Healthc Eng       Date:  2021-10-18       Impact factor: 2.682

6.  Bioinformatics Analysis Reveals Crosstalk Among Platelets, Immune Cells, and the Glomerulus That May Play an Important Role in the Development of Diabetic Nephropathy.

Authors:  Xinyue Yao; Hong Shen; Fukai Cao; Hailan He; Boyu Li; Haojun Zhang; Xinduo Zhang; Zhiguo Li
Journal:  Front Med (Lausanne)       Date:  2021-06-24

7.  MiR-142-3p ameliorates high glucose-induced renal tubular epithelial cell injury by targeting BOD1.

Authors:  Ningmin Zhao; Qing Luo; Ruijuan Lin; Qiaoyan Li; Peizhi Ma
Journal:  Clin Exp Nephrol       Date:  2021-06-18       Impact factor: 2.617

Review 8.  The Role of Semaphorins in Metabolic Disorders.

Authors:  Qiongyu Lu; Li Zhu
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

9.  Methylenetetrahydrofolate reductase genetic polymorphism and the risk of diabetic nephropathy in type 2 diabetic patients.

Authors:  Hui Guan; Meng-Di Xia; Miao Wang; Ying-Jie Guan; Xiao-Chen Lyu
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817

10.  Loss of lncRNA MIAT ameliorates proliferation and fibrosis of diabetic nephropathy through reducing E2F3 expression.

Authors:  Ting-Ting Ji; Ying-Hui Qi; Xiao-Ying Li; Bo Tang; Ya-Kun Wang; Peng-Xi Zheng; Weiliang Li; Xiaolei Qu; Linhong Feng; Shou-Jun Bai
Journal:  J Cell Mol Med       Date:  2020-10-03       Impact factor: 5.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.